{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:02:19Z","timestamp":1773745339135,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11010-014-2003-9","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T13:24:31Z","timestamp":1397049871000},"page":"201-209","source":"Crossref","is-referenced-by-count":20,"title":["Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction"],"prefix":"10.1007","volume":"391","author":[{"given":"David W. J.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Yat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalna A.","family":"Meens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer M.","family":"Johri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray F.","family":"Matangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"key":"2003_CR1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","volume":"298","author":"DJ Barker","year":"1989","unstructured":"Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298:564","journal-title":"Br Med J"},{"key":"2003_CR2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(86)91340-1","volume":"327","author":"DJP Barker","year":"1986","unstructured":"Barker DJP, Osmond C (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. The Lancet 327:1077\u20131081","journal-title":"The Lancet"},{"key":"2003_CR3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/STROKEAHA.108.538025","volume":"40","author":"E Kajantie","year":"2009","unstructured":"Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJP (2009) Pre-eclampsia is associated with increased risk of stroke in the adult offspring. Stroke 40:1176\u20131180","journal-title":"Stroke"},{"key":"2003_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajog.2008.06.035","volume":"200","author":"GN Smith","year":"2009","unstructured":"Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, White RR, Roddy M, Hladunewich M, Pre-Eclampsia New Emerging Team (PE-NET) (2009) A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 200:58","journal-title":"Am J Obstet Gynecol"},{"key":"2003_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1440-1681.2003.03836.x","volume":"30","author":"JA Feng","year":"2003","unstructured":"Feng JA, Perry G, Mori T, Hayashi T, Oparil S, Chen YF (2003) Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice. Clin Exp Pharmacol Physiol 30:343\u2013349","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2003_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.7839143","volume":"267","author":"SW John","year":"1995","unstructured":"John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679\u2013681","journal-title":"Science"},{"key":"2003_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.yjmcc.2011.01.010","volume":"50","author":"KL Ellis","year":"2011","unstructured":"Ellis KL, Newton-Cheh C, Wang TJ, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Skelton L, Davis N, Yandle TG, Troughton RW, Richards AM, Cameron VA (2011) Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J Mol Cell Cardiol 50:695\u2013701","journal-title":"J Mol Cell Cardiol"},{"key":"2003_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.328","volume":"41","author":"C Newton-Cheh","year":"2009","unstructured":"Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J, Morgenthaler NG, Bergmann A, Blankenberg S, Kee F, Nilsson P, Yin X, Peltonen L, Vartiainen E, Salomaa V, Hirschhorn JN, Melander O, Wang TJ (2009) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41:348\u2013353","journal-title":"Nat Genet"},{"key":"2003_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","volume":"48","author":"S Rubattu","year":"2006","unstructured":"Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, Volpe M, Stella P (2006) Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48:499\u2013505","journal-title":"J Am Coll Cardiol"},{"key":"2003_CR10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.100.16.1722","volume":"100","author":"S Rubattu","year":"1999","unstructured":"Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K (1999) The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 100:1722\u20131726","journal-title":"Circulation"},{"key":"2003_CR11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.regpep.2013.08.006","volume":"186","author":"DW Armstrong","year":"2013","unstructured":"Armstrong DW, Tse MY, O\u2019Tierney PF, Wong PG, Ventura NM, Janzen-Pang JJ, Matangi MF, Johri AM, Croy BA, Adams MA, Pang SC (2013) Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy. Regul Pept 186:108\u2013115","journal-title":"Regul Pept"},{"key":"2003_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/JOE-07-0130","volume":"194","author":"SJ Sangaralingham","year":"2007","unstructured":"Sangaralingham SJ, Tse MY, Pang SC (2007) Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. J Endocrinol 194:143\u2013152","journal-title":"J Endocrinol"},{"key":"2003_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-005-3672-1","volume":"276","author":"E Angelis","year":"2005","unstructured":"Angelis E, Tse MY, Pang SC (2005) Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem 276:121\u2013131","journal-title":"Mol Cell Biochem"},{"key":"2003_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11010-010-0591-6","volume":"346","author":"DW Armstrong","year":"2011","unstructured":"Armstrong DW, Tse MY, Melo LG, Pang SC (2011) Altered expression of the natriuretic peptide system in genetically modified heme oxygenase-1 mice treated with high dietary salt. Mol Cell Biochem 346:57\u201367","journal-title":"Mol Cell Biochem"},{"key":"2003_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y04-137","volume":"83","author":"AR Hohimer","year":"2005","unstructured":"Hohimer AR, Davis LE, Hatton DC (2005) Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol 83:191\u2013197","journal-title":"Can J Physiol Pharmacol"},{"key":"2003_CR16","doi-asserted-by":"crossref","first-page":"30245","DOI":"10.1074\/jbc.M102174200","volume":"276","author":"Q Liang","year":"2001","unstructured":"Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276:30245\u201330253","journal-title":"J Biol Chem"},{"key":"2003_CR17","doi-asserted-by":"crossref","first-page":"37178","DOI":"10.1074\/jbc.M103731200","volume":"276","author":"YS Dai","year":"2001","unstructured":"Dai YS, Markham BE (2001) p300 functions as a coactivator of transcription factor GATA-4. J Biol Chem 276:37178\u201337185","journal-title":"J Biol Chem"},{"key":"2003_CR18","first-page":"868","volume":"118","author":"T Morimoto","year":"2008","unstructured":"Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, Komeda M, Fujita M, Shimatsu A, Kita T, Hasegawa K (2008) The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118:868\u2013878","journal-title":"J Clin Invest"},{"key":"2003_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.lfs.2010.10.009","volume":"87","author":"H Sun","year":"2010","unstructured":"Sun H, Yang X, Zhu J, Lv T, Chen Y, Chen G, Zhong L, Li Y, Huang X, Huang G, Tian J (2010) Inhibition of p300-HAT results in a reduced histone acetylation and down-regulation of gene expression in cardiac myocytes. Life Sci 87:707\u2013714","journal-title":"Life Sci"},{"key":"2003_CR20","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1074\/jbc.M707391200","volume":"283","author":"T Takaya","year":"2008","unstructured":"Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, Hasegawa K (2008) Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem 283:9828\u20139835","journal-title":"J Biol Chem"},{"key":"2003_CR21","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/MCB.23.10.3593-3606.2003","volume":"23","author":"T Yanazume","year":"2003","unstructured":"Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T (2003) Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 23:3593\u20133606","journal-title":"Mol Cell Biol"},{"key":"2003_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","volume":"54","author":"JS Floras","year":"2009","unstructured":"Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54:375\u2013385","journal-title":"J Am Coll Cardiol"},{"key":"2003_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","volume":"111","author":"SR Houser","year":"2012","unstructured":"Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch WJ, American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology (2012) Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111:131\u2013150","journal-title":"Circ Res"},{"key":"2003_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.CIR.95.1.169","volume":"95","author":"B Rundqvist","year":"1997","unstructured":"Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P (1997) Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95:169\u2013175","journal-title":"Circulation"},{"key":"2003_CR25","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","volume":"292","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahl\u00f6f B (2004) Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292:2350\u20132356","journal-title":"JAMA"},{"key":"2003_CR26","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","volume":"292","author":"PM Okin","year":"2004","unstructured":"Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahl\u00f6f B, LIFE Study Investigators (2004) Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292:2343\u20132349","journal-title":"JAMA"},{"key":"2003_CR27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S, Heart Outcomes Prevention Evaluation (HOPE) Investigators (2001) Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104:1615\u20131621","journal-title":"Circulation"},{"key":"2003_CR28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","volume":"97","author":"P Verdecchia","year":"1998","unstructured":"Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellati C (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97:48\u201354","journal-title":"Circulation"},{"key":"2003_CR29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.35.2.580","volume":"35","author":"G Schillaci","year":"2000","unstructured":"Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F (2000) Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35:580\u2013586","journal-title":"Hypertension"},{"key":"2003_CR30","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/hc4201.097944","volume":"104","author":"P Verdecchia","year":"2001","unstructured":"Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G (2001) Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 104:2039\u20132044","journal-title":"Circulation"},{"key":"2003_CR31","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561\u20131566","journal-title":"N Engl J Med"},{"key":"2003_CR32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehr378","volume":"33","author":"MA Rosenberg","year":"2012","unstructured":"Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ (2012) Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 33:904\u2013912","journal-title":"Eur Heart J"},{"key":"2003_CR33","first-page":"856","volume":"306","author":"GC Kane","year":"2011","unstructured":"Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 306:856\u2013863","journal-title":"JAMA"},{"key":"2003_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.105.601005","volume":"114","author":"JE Moller","year":"2006","unstructured":"Moller JE, Pellikka PA, Hillis GS, Oh JK (2006) Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction. Circulation 114:438\u2013444","journal-title":"Circulation"},{"key":"2003_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/jme.1.02138","volume":"38","author":"LJ Ellmers","year":"2007","unstructured":"Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA (2007) Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38:245\u2013257","journal-title":"J Mol Endocrinol"},{"key":"2003_CR36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cvr\/cvn341","volume":"81","author":"CF Rueda-Clausen","year":"2009","unstructured":"Rueda-Clausen CF, Morton JS, Davidge ST (2009) Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res 81:713\u2013722","journal-title":"Cardiovasc Res"},{"key":"2003_CR37","doi-asserted-by":"crossref","first-page":"254.e1","DOI":"10.1016\/j.ajog.2008.06.056","volume":"199","author":"F Crispi","year":"2008","unstructured":"Crispi F, Hernandez-Andrade E, Pelsers MM, Plasencia W, Benavides-Serralde JA, Eixarch E, Le Noble F, Ahmed A, Glatz JF, Nicolaides KH, Gratacos E (2008) Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol 199:254.e1\u2013254.e8","journal-title":"Am J Obstet Gynecol"},{"key":"2003_CR38","doi-asserted-by":"crossref","first-page":"45.e1","DOI":"10.1016\/j.ajog.2010.02.044","volume":"203","author":"M Comas","year":"2010","unstructured":"Comas M, Crispi F, Cruz-Martinez R, Martinez JM, Figueras F, Gratac\u00f3s E (2010) Usefulness of myocardial tissue Doppler vs conventional echocardiography in the evaluation of cardiac dysfunction in early-onset intrauterine growth restriction. Am J Obstet Gynecol 203:45.e1\u201345.e7","journal-title":"Am J Obstet Gynecol"},{"key":"2003_CR39","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/CIRCULATIONAHA.110.937995","volume":"121","author":"F Crispi","year":"2010","unstructured":"Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, Ahmed A, Gratac\u00f3s E (2010) Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121:2427\u20132436","journal-title":"Circulation"},{"key":"2003_CR40","doi-asserted-by":"crossref","first-page":"57.e1","DOI":"10.1016\/j.ajog.2011.03.010","volume":"205","author":"M Comas","year":"2011","unstructured":"Comas M, Crispi F, Cruz-Martinez R, Figueras F, Gratacos E (2011) Tissue-Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age fetuses. Am J Obstet Gynecol 205:57.e1\u201357.e6","journal-title":"Am J Obstet Gynecol"},{"key":"2003_CR41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000324863","volume":"100","author":"M Agoudemos","year":"2011","unstructured":"Agoudemos M, Reinking BE, Koppenhafer SL, Segar JL, Scholz TD (2011) Programming of adult cardiovascular disease following exposure to late-gestation hyperglycemia. Neonatology 100:198\u2013205","journal-title":"Neonatology"},{"key":"2003_CR42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejheart.2008.06.005","volume":"10","author":"RN Doughty","year":"2008","unstructured":"Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators, Doughty RN, Klein AL, Poppe KK, Gamble GD, Dini FL, M\u00f8ller JE, Quintana M, Yu CM, Whalley GA (2008) Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis. Eur J Heart Fail 10:786\u2013792","journal-title":"Eur J Heart Fail"},{"key":"2003_CR43","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:1948\u20131955","journal-title":"J Am Coll Cardiol"},{"key":"2003_CR44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260\u2013269","journal-title":"N Engl J Med"},{"key":"2003_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/CIRCIMAGING.109.908152","volume":"3","author":"DJ Holland","year":"2010","unstructured":"Holland DJ, Prasad SB, Marwick TH (2010) Prognostic implications of left ventricular filling pressure with exercise. Circ Cardiovasc Imaging 3:149\u2013156","journal-title":"Circ Cardiovasc Imaging"},{"key":"2003_CR46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.296.10.1242","volume":"296","author":"PM Okin","year":"2006","unstructured":"Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahl\u00f6f B (2006) Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 296:1242\u20131248","journal-title":"JAMA"},{"key":"2003_CR47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","volume":"89","author":"SM Vaziri","year":"1994","unstructured":"Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89:724\u2013730","journal-title":"Circulation"},{"key":"2003_CR48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. JAMA 271:840\u2013844","journal-title":"JAMA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-014-2003-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2003-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:15:28Z","timestamp":1559355328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-014-2003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2003"],"URL":"https:\/\/doi.org\/10.1007\/s11010-014-2003-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}